PureHealth Proposes Dh343 Million Dividend Following Stellar First Year Post-Listing
Proposed Dh343 Million Dividend Highlights PureHealth's Strong Financial Performance and Commitment to Shareholder Returns Following Successful First Year as a Publicly Listed Company.
Healthcare Giant’s Strong Financial Performance in 2024 Paves the Way for First-Ever Dividend Distribution, Reflecting Commitment to Shareholder Value
PureHealth Holding, the largest healthcare group in the Middle East, has proposed a Dh343 million dividend for the 2024 financial year, marking a significant milestone in the company’s journey as a publicly listed entity. This dividend proposal, representing 20% of the Group’s net profit, follows the completion of PureHealth’s first full year post-listing on the Abu Dhabi Securities Exchange (ADX) in December 2023.
The proposed Dh3.09 fils per share payout, which is subject to approval at the upcoming Annual General Meeting (AGM) on April 9, 2025, reflects the Group’s strong financial position and its ability to deliver sustainable returns to shareholders while continuing its expansion strategy.
A Year of Strong Financial Performance
In its inaugural year as a publicly listed company, PureHealth achieved exceptional financial results, posting revenues of Dh25.8 billion, EBITDA of Dh4.1 billion, and a net profit of Dh1.7 billion. This robust performance was underpinned by an impressive cash position of Dh11.9 billion, with a low leverage ratio of approximately 0.1x—further highlighting the Group’s financial stability and flexibility.
“The proposed dividend not only underscores our strong balance sheet but also highlights our ability to generate consistent returns for shareholders,” said a statement from the company. “While rewarding our investors, the decision to retain a significant portion of profits will ensure financial flexibility to support future growth, including the potential for global expansion opportunities.”
Strategic Expansion and Acquisitions
In line with its growth trajectory, PureHealth recently expanded its reach through the acquisition of a 60% stake in Hellenic Healthcare Group, a move that bolsters its capabilities and strengthens its position in the global healthcare sector. The acquisition was made in collaboration with CVC, a global private equity firm, which will remain a minority partner in the entity.
This acquisition is a part of PureHealth’s broader strategy to expand its operational footprint and acquire key assets that align with its ambition to be a leading healthcare provider not only in the Middle East but globally. The Group’s strong financial foundation allows it to continue pursuing such strategic acquisitions without compromising its capital position.
A Commitment to Shareholder Value
The dividend proposal comes at a time when PureHealth is focused on delivering long-term value to its investors. The decision to distribute 20% of its profits reflects the Group’s commitment to returning value to shareholders, while simultaneously positioning the company for further growth and global expansion.
“This dividend distribution represents a key milestone in our journey as a public company. It demonstrates our ability to generate returns, strengthen shareholder confidence, and continue expanding our operations,” the statement concluded.
Looking Ahead
As PureHealth enters its second year as a publicly listed entity, the Group’s strong performance, coupled with its aggressive growth strategy, positions it well to capitalize on emerging opportunities in the global healthcare market. With continued focus on acquisitions, expansion, and operational excellence, PureHealth is poised to solidify its leadership in the healthcare sector both regionally and internationally.
The upcoming AGM will be a crucial event for shareholders, as the dividend proposal will mark a significant acknowledgment of PureHealth’s growth and commitment to shareholder value, while the company continues to execute its ambitious growth agenda.
